Synopsis
0
VMF
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Kirsch Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dr. Paul Lohmann GmbH & Co. KGaA
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Parenteral
API Stability Enhancers
Solubilizers
Thickeners and Stabilizers
Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
89
PharmaCompass offers a list of Betamethasone Sodium Phosphate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Betamethasone Sodium Phosphate manufacturer or Betamethasone Sodium Phosphate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Betamethasone Sodium Phosphate manufacturer or Betamethasone Sodium Phosphate supplier.
A Vista-Methasone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vista-Methasone, including repackagers and relabelers. The FDA regulates Vista-Methasone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vista-Methasone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Vista-Methasone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Vista-Methasone supplier is an individual or a company that provides Vista-Methasone active pharmaceutical ingredient (API) or Vista-Methasone finished formulations upon request. The Vista-Methasone suppliers may include Vista-Methasone API manufacturers, exporters, distributors and traders.
click here to find a list of Vista-Methasone suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Vista-Methasone DMF (Drug Master File) is a document detailing the whole manufacturing process of Vista-Methasone active pharmaceutical ingredient (API) in detail. Different forms of Vista-Methasone DMFs exist exist since differing nations have different regulations, such as Vista-Methasone USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Vista-Methasone DMF submitted to regulatory agencies in the US is known as a USDMF. Vista-Methasone USDMF includes data on Vista-Methasone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Vista-Methasone USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Vista-Methasone suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Vista-Methasone Drug Master File in Japan (Vista-Methasone JDMF) empowers Vista-Methasone API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Vista-Methasone JDMF during the approval evaluation for pharmaceutical products. At the time of Vista-Methasone JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Vista-Methasone suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Vista-Methasone Drug Master File in Korea (Vista-Methasone KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Vista-Methasone. The MFDS reviews the Vista-Methasone KDMF as part of the drug registration process and uses the information provided in the Vista-Methasone KDMF to evaluate the safety and efficacy of the drug.
After submitting a Vista-Methasone KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Vista-Methasone API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Vista-Methasone suppliers with KDMF on PharmaCompass.
A Vista-Methasone CEP of the European Pharmacopoeia monograph is often referred to as a Vista-Methasone Certificate of Suitability (COS). The purpose of a Vista-Methasone CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Vista-Methasone EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Vista-Methasone to their clients by showing that a Vista-Methasone CEP has been issued for it. The manufacturer submits a Vista-Methasone CEP (COS) as part of the market authorization procedure, and it takes on the role of a Vista-Methasone CEP holder for the record. Additionally, the data presented in the Vista-Methasone CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Vista-Methasone DMF.
A Vista-Methasone CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Vista-Methasone CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Vista-Methasone suppliers with CEP (COS) on PharmaCompass.
A Vista-Methasone written confirmation (Vista-Methasone WC) is an official document issued by a regulatory agency to a Vista-Methasone manufacturer, verifying that the manufacturing facility of a Vista-Methasone active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Vista-Methasone APIs or Vista-Methasone finished pharmaceutical products to another nation, regulatory agencies frequently require a Vista-Methasone WC (written confirmation) as part of the regulatory process.
click here to find a list of Vista-Methasone suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Vista-Methasone as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Vista-Methasone API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Vista-Methasone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Vista-Methasone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Vista-Methasone NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Vista-Methasone suppliers with NDC on PharmaCompass.
Vista-Methasone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vista-Methasone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Vista-Methasone GMP manufacturer or Vista-Methasone GMP API supplier for your needs.
A Vista-Methasone CoA (Certificate of Analysis) is a formal document that attests to Vista-Methasone's compliance with Vista-Methasone specifications and serves as a tool for batch-level quality control.
Vista-Methasone CoA mostly includes findings from lab analyses of a specific batch. For each Vista-Methasone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vista-Methasone may be tested according to a variety of international standards, such as European Pharmacopoeia (Vista-Methasone EP), Vista-Methasone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vista-Methasone USP).
